Press "Enter" to skip to content

New patent for Kowa Pharms drug SEGLENTIS

0
Copyright © DrugPatentWatch. Originally published at https://www.drugpatentwatch.com/blog/

Annual Drug Patent Expirations for SEGLENTIS
Annual Drug Patent Expirations for SEGLENTIS

Seglentis is a drug marketed by Kowa Pharms and is included in one NDA. It is available from one supplier. There are six patents protecting this drug.

This drug has ninety-one patent family members in thirty-five countries.

The generic ingredient in SEGLENTIS is celecoxib; tramadol hydrochloride. One supplier is listed for this compound. Additional details are available on the celecoxib; tramadol hydrochloride profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

» Start Your Free Trial Today «

Copyright © DrugPatentWatch. Originally published at
DrugPatentWatch - Make Better Decisions